UK Women Innovators Network

UK Women Innovators Network (UKWIN)

UKWIN Graphic Identifier

 

 

 

 

The UK Women Innovators Network (UKWIN) program has a mission to increase the number of UK women who participate in innovation. This includes getting women involved and prepared to take leadership roles in all stages of the commercialization process - from idea generation, through research and discovery, to patenting, and ultimately to products and processes in the marketplace. UKWIN will provide a forum for women innovators that is supportive and allows them to exchange experience, advice, and strategies for taking their innovations to the next level.

Program activities will include social/networking events, topical discussion roundtables, keynote speakers, education on navigating the commercialization process and the requisite resources, entrepreneurial training, and coaches/mentors.

Sign Up for UKWIN Updates

UKWIN Rising Strong! Conference

Featured Speaker: Dr. Linda P. Dwoskin

Dr. Dwoskin is an Endowed Professor in Pharmaceutical Education at the University of Kentucky College of Pharmacy. She received her B.S. (1974) in psychology from Syracuse University and Ph.D. (1983) from the Department of Pharmacology at the University of Minnesota. She was a postdoctoral fellow in endocrinology at the Oregon Health Science Center and in the Department of Pharmacology at the University of Colorado Health Science Center. Dr. Dwoskin joined the faculty at the University of Kentucky in 1988 as an assistant professor. She currently holds several other academic appointments including professor, Department of Behavioral Sciences; adjunct faculty, University of Kentucky Graduate Center; associate, the University of Kentucky Center on Drug Abuse Translation; associate, Multi-disciplinary Research Center on Drug and Alcohol Abuse; and associate, Center of Membrane Sciences. Dr. Dwoskin has been awarded the University of Kentucky Wethington Award for Meritorious Performance in Research (2002-2016). She was chosen in 2005-2006 for a University Research Professorship, recognizing her outstanding research and her distinguished record of achievement in her field. Her research has resulted in over 249 peer-reviewed research articles, 352 abstracts of research presentations and 110 patents and patent applications. Dr. Dwoskin's major research focus is drug discovery in neuropharmacology, i.e., the development of novel therapeutic candidates for the treatment of psychostimulant abuse, specifically for nicotine and methamphetamine abuse. In particular, her focus is the design and discovery of subtype-selective neuronal nicotinic receptor antagonists as novel tobacco smoking cessation agents and of modulators of vesicular monoamine transporter function as novel treatments for methamphetamine abuse. In her collaborators' labs, promising therapeutic candidates are also tested in locomotor activity assays and drug discrimination assays to determine if they inhibit the stimulant effects and interoceptive cues associated with psychostimulant use, as well as in intravenous self-administration assays to determine if they inhibit the rewarding effect of these drugs of abuse. Another focus of Dr. Dwoskin's research is to determine the role of environmental and genetic factors as determinants of individual responsiveness to drugs of abuse and as determinants of an individual's potential for abuse liability. Using an animal model, the relationship between dopaminergic function (release, reuptake, and metabolism) in striatum, nucleus accumbens, medial prefrontal cortex, and orbital prefrontal cortex and an individual's behavior in novelty-seeking, psychostimulant self-administration, and delay-discounting assays are evaluated as predictors of an individual's responsiveness to drugs of abuse. Several drugs discovered in her laboratory at the University of Kentucky are currently in various phases of clinical development.

Panelist: Nicole Jenkins, Ph.D.

Nicole Thorne Jenkins is the executive associate dean for Administration, Faculty, and Research and the Von Allmen Endowed Chair of Accountancy in the Gatton College of Business and Economics at the University of Kentucky. She has been a member of the faculty at the University of Kentucky since 2012 and held prior appointments at Vanderbilt University and Washington University in St Louis. Dr. Jenkins received her Ph.D. in accounting from the University of Iowa and she completed her undergraduate work in accounting and finance at Drexel University. Her research interests include audit failures, the costs/benefits of share repurchases, and the effect of social networks on performance outcomes. Her teaching experience has focused on financial reporting topics in both graduate and undergraduate programs. Dr. Jenkins is a certified public accountant and is the 2018-2019 president of the Financial Accounting & Reporting Section of the American Accounting Association. Prior to becoming an academic, she was an auditor at PriceWaterhouse and Coopers & Lybrand. Additionally, she consults and serves as an expert witness in matters related to financial reporting, valuation, and estimation of damages.

Panelist: Stephanie Jenkins

Stephanie Jenkins is a respiratory therapist at the University of Kentucky Children's Hospital in the Neonatal Intensive Care Unit (NICU), where she provides specialized care and treatment to critically ill newborns. Her work in NICU inspired her technology and led to the creation of her company Kangaroo Keeper. Stephanie graduated from the Office of Technology Commercialization (OTC) and Von Allmen Center for Entrepreneurship's (VACE) UKAccel program and is currently participating in VACE's Entrepreneurship Bootcamp.

Panelist: Elaine Ramesh

Elaine Ramesh is a licensed patent attorney and partner at FLENER IP & BUSINESS LAW in Chicago, Illinois and has expertise in the preparation and prosecution of U.S. and foreign chemical patent applications in the areas of pharmaceuticals, cosmetics, animal health, water treatment, and agrochemicals. In addition, she counsels clients on patent and related transaction matters and provides strategic patent portfolio and due diligence services. 

She received her Ph.D. in organic chemistry under the guidance of Nobel Laureate Sir Derek H.R. Barton at Texas A&M University.  While at law school, she was a member of the Law Review, received the esteemed Order of the Coif, and was a Chicago-Kent Legal Scholar. Elaine's clients benefit from her prior experience as an in-house attorney for many years at companies such as Nalco Chemical Company where she prepared, prosecuted and managed a large portfolio of patents; Takeda Pharmaceuticals North America, Inc. where she interfaced with the Japanese R&D team counseling on patent strategy, ran due diligence assessments, maintained a trademark portfolio of over 100 pharmaceutical trademarks, prosecuted the company's US patent portfolio, and coordinated patent litigation, among other efforts; and Winston Pharmaceuticals; as well as her prior experience at two different intellectual property law firms, drafting and prosecuting a wide variety of patent applications. Her skill at applying her academic background as a research scientist to intellectual property matters is well respected and greatly appreciated by her clients and colleagues alike. 

Panelist: Christine Trinkle, Ph.D.

Christine Trinkle, Ph.D. is an associate professor in the University of Kentucky's (UK) Mechanical Engineering department. Her research areas are bioengineering & biomechanics, fluid mechanics, and micro & nano engineering. Prior to coming back to UK, Christine was a research assistant at the University of California, Berkeley, BioPOETS (Biologically-inspired Photonics-Optofluidic-Electronic Technology and Science) Group. She has a bachelor's of science degree in mechanical engineering and a master's of science degree in mechanical engineering from the UK. She obtained her Ph.D. in mechanical engineering from the University of California, Berkeley. Christine's research interests are biologically-inspired design, MEMS, micro-scale design and fabrication, microfluidic system and precision machine design.